1. Prospect and progress of personalized peptide vaccinations for advanced cancers.
    Shinjiro Sakamoto et al, 2016, Expert Opin Biol Ther CrossRef
  2. Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis
    Bodo E. Lippitz et al, 2016, OncoImmunology CrossRef
  3. Immunotherapeutic Approaches to Biliary Cancer
    Urvi A. Shah et al, 2017, Curr. Treat. Options in Oncol. CrossRef
  4. Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy
    Hidemitsu Kitamura et al, 2017, Cancer Sci CrossRef
  5. Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer
    Shinjiro Sakamoto et al, 2017, Clinical Lung Cancer CrossRef
  6. Immunotherapy as a Treatment for Biliary Tract Cancers: A Review of Approaches with an Eye to the Future
    Alex B. Blair et al, 2017, Current Problems in Cancer CrossRef
  7. Personalized peptide vaccines for cancer therapy: current progress and state of the art
    Satoshi Wada et al, 2017, Expert Review of Precision Medicine and Drug Development CrossRef
  8. Change in Palliative Performance Scale (PPS) Predicts Survival in Patients with Terminal Cancer
    Jee Hye Oh et al, 2017, Korean J Hosp Palliat Care CrossRef
  9. REVIEW | Biliary Tract Cancer: State of the Art and potential role of DNA Damage Repair
    Angela Lamarca et al, 2018, Cancer Treatment Reviews CrossRef
  10. Review Article: Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma
    Anwaar Saeed et al, 2019, Clinical Colorectal Cancer CrossRef
  11. null
    Nobukazu Komatsu et al, 2013 CrossRef
  12. null
    Masato Okamoto, 2016 CrossRef
  13. null
    Masanori Noguchi, 2016 CrossRef
  14. Prospects for a personalized peptide vaccine against lung cancer
    Yoshiro Nakahara et al, 2019, Expert Review of Vaccines CrossRef
  15. Personalized peptide vaccination: A novel immunotherapeutic approach for advanced cancer
    Tetsuro Sasada et al, 2012, Human Vaccines & Immunotherapeutics CrossRef
  16. Current status of immunotherapy for the treatment of biliary tract cancer
    Ryuji Takahashi et al, 2013, Human Vaccines & Immunotherapeutics CrossRef
  17. Immunobiology of Cholangiocarcinoma
    Emilien Loeuillard et al, 2019, JHEP Reports CrossRef
  18. null
    Jonathan D. Mizrahi et al, 2019 CrossRef
  19. Personalized peptide vaccination for advanced colorectal cancer
    Tetsuro Sasada et al, 2015, OncoImmunology CrossRef
  20. Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination
    Shinjiro Sakamoto et al, 2015, Human Vaccines & Immunotherapeutics CrossRef
  21. IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells
    Yosuke Ohno et al, 2016, Cancer Immunol Immunother CrossRef
  22. Immunotherapy of biliary tract cancer
    Yi Chai, 2016, Tumor Biol. CrossRef
  23. A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer
    Takahisa Shirahama et al, 2017, Cancer Sci CrossRef
  24. CD4/CD8 ratio is a prognostic factor in IgG nonresponders among peptide vaccine‐treated ovarian cancer patients
    Kayoko Waki et al, 2020, Cancer Sci CrossRef
  25. Development of tumour peptide vaccines: From universalization to personalization
    Minjun Ma et al, 2020, Scand J Immunol CrossRef
  26. Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
    Noomi Vainer et al, 2018, Oncotarget CrossRef
  27. Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients
    Kayoko Waki et al, 2020, Cancer Immunol Immunother CrossRef
  28. A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs)
    Shuting Han et al, 2020, Cancers CrossRef
  29. Therapy for advanced cholangiocarcinoma: Current knowledge and future potential
    Mingxun Wang et al, 2020, J Cell Mol Med CrossRef
  30. New Horizons for Precision Medicine in Biliary Tract Cancers.
    Juan W Valle et al, 0 CrossRef
  31. Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers
    Dan Høgdall et al, 2020, Clin Cancer Res CrossRef
  32. Immunotherapy in cholangiocarcinoma
    Raed Al-Rajabi et al, 2021 CrossRef
  33. null
    Bonala Sabeerabi et al, 2020 CrossRef
  34. Integrity of circulating cell-free DNA as a prognostic biomarker for vaccine therapy in patients with nonsmall cell lung cancer.
    Kayoko Waki et al, 2021, Immunopharmacol Immunotoxicol CrossRef
  35. The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
    Oraianthi Fiste et al, 2021, Vaccines CrossRef
  36. Immunotherapy for cholangiocarcinoma: a 2021 update
    Nikolaos Charalampakis et al, 2021, Immunotherapy CrossRef
  37. Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
    Ashish Manne et al, 2021, Front. Oncol. CrossRef
  38. Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers
    Ruyin Chen et al, 2022, Cancer Letters CrossRef